SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (82814)2/14/2000 11:20:00 AM
From: Rose K  Read Replies (1) of 120523
 
EP #3 (2/14 announces earnings and stock split.

Monday, February 14, 2000, 6:00 AM ET

Pharmaceutical Company Announces a 2 for 1 Split

EP #3 (2/14) announced that the Company's Board of Directors has approved a 2 for 1 split of
the Company's common shares and ADRs. The Israel-based company has set a payable date of March 24th. The Company currently has approximately 62 million shares outstanding.

Also announced was a 4th Quarter dividend of $0.11 per share (pre-split), payable to shareholders of record as of February 21st and payable on March 15th. The dividend and split announcements were made in conjunction with 4th quarter earnings, which came in at $0.64 per share (adjusted). First Call estimates had placed earnings at $0.62 per share.

EP #3 (2/14) is Israel's largest pharmaceutical company. The Company develops, manufactures and markets branded and generic drugs, drug ingredients and medical disposables. The Company makes the branded drug Copaxone, which is used to treat multiple sclerosis. Over 80% of the Company's revenues are generated outside of Israel, mostly in the US and Europe.

Shares of EP #3 (2/14) were first traded in the US in 1987. ADRs were issued at $9.25. The Company was originally founded in Israel in 1944. This is the second forward split for the Company. The first 2:1 split came in April 1993, while the stock was trading near $44.00. The stock has been surging since November 1999, trading from $50 to a recent high of $78.62 on January 19th. The
65-day ADV is 502,000 shares traded. The pharmaceutical companies have been under pressure since early December, but this stock is out-performing the sector.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News